Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / DNLI - Denali rallies on deal with Biogen in Parkinson's disease


DNLI - Denali rallies on deal with Biogen in Parkinson's disease

  • Denali Therapeutics (NASDAQ:DNLI) jumps 33% premarket on increased volume in reaction to its agreement with Biogen (NASDAQ:BIIB) to co-develop and co-commercialize its small molecule leucine-rich repeat kinase 2 (LRRK2) inhibitors for the potential treatment of Parkinson's disease.
  • More news on: Denali Therapeutics Inc., Biogen Inc., Healthcare stocks news, Stocks on the move,
  • Read more ...
Stock Information

Company Name: Denali Therapeutics Inc.
Stock Symbol: DNLI
Market: NASDAQ
Website: denalitherapeutics.com

Menu

DNLI DNLI Quote DNLI Short DNLI News DNLI Articles DNLI Message Board
Get DNLI Alerts

News, Short Squeeze, Breakout and More Instantly...